Table 2.
Bay leaves decrease serum cholesterol in subjects with type 2 diabetes
Doses of bay leaves and placebo (g/day) | Fasting serum cholesterol (mmol/L) |
||||
---|---|---|---|---|---|
Before intake of bay leaves |
During intake of bay leaves |
After intake of bay leaves |
|||
Day 0 | Day 10 | Day 20 | Day 30 | Day 40 | |
Bay Leaves 1 | 6.34 ± 2.69a | 5.40 ± 2.74abc | 5.09 ± 1.63bc | 4.84 ± 1.55c | 5.97 ± 1.63ab |
Bay Leaves 2 | 5.77 ± 1.16a | 4.58 ± 0.98b | 4.34 ± 0.88b | 4.60 ± 1.03b | 5.59 ± 1.22a |
Bay Leaves 3 | 5.84 ± 1.81a | 5.04 ± 1.66b | 4.47 ± 1.58b | 4.63 ± 1.22b | 4.42 ± 0.96b |
Placebo 1 | 5.74 ± 0.70a | 5.72 ± 1.03a | 5.66 ± 0.57a | 5.90 ± 0.67a | 5.59 ± 0.72a |
Conditions defined in Table 1. Means in the same row, with different superscripts, are significantly different at p<0.05.
For example, the mean of 6.34 ± 2.69a is not different from 5.40 ± 2.74abc and 5.97 ± 1.63ab (all three contain a superscript (a)) but is different from 5.09 ± 1.63bc and 4.84 ± 1.55c. Similarly, mean values with common superscripts b and or c are also not significantly different.